APA (7th ed.) Citation

R, L., S, D. G., L, M., M, B., U, B., F, M., . . . S, D. P. (2004). Rosiglitazone prevents the impairment of human islet function induced by fatty acids: Evidence for a role of PPARgamma2 in the modulation of insulin secretion. American journal of physiology. Endocrinology and metabolism, 286(4), E560. https://doi.org/10.1152/ajpendo.00561.2002

Chicago Style (17th ed.) Citation

R, Lupi, Del Guerra S, Marselli L, Bugliani M, Boggi U, Mosca F, Marchetti P, and Del Prato S. "Rosiglitazone Prevents the Impairment of Human Islet Function Induced by Fatty Acids: Evidence for a Role of PPARgamma2 in the Modulation of Insulin Secretion." American Journal of Physiology. Endocrinology and Metabolism 286, no. 4 (2004): E560. https://doi.org/10.1152/ajpendo.00561.2002.

MLA (9th ed.) Citation

R, Lupi, et al. "Rosiglitazone Prevents the Impairment of Human Islet Function Induced by Fatty Acids: Evidence for a Role of PPARgamma2 in the Modulation of Insulin Secretion." American Journal of Physiology. Endocrinology and Metabolism, vol. 286, no. 4, 2004, p. E560, https://doi.org/10.1152/ajpendo.00561.2002.